Skip to content

The Impact of Group Cognitive Behavioral Therapy on the Mental Health, Stigma, and Social Capital of Patients with Severe Psychiatric Disorders and Its Effect on Their Caregivers

The Impact of Group Cognitive Behavioral Therapy on the Mental Health, Stigma, and Social Capital of Patients with Severe Psychiatric Disorders (Bipolar Disorder, Schizophrenia, and Schizoaffective Disorder) and Its Effect on Their Caregivers

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251128068139N1
Enrollment
60
Registered
2025-12-14
Start date
2025-12-22
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Severe Psychiatric Disorders. Condition 2: Severe Psychiatric Disorders. Condition 3: Severe Psychiatric Disorders. Schizophrenia Bipolar disorder Schizoaffective disorders

Interventions

Intervention 1: First intervention group: Patients with severe psychiatric disorders (bipolar, schizophrenia, and schizoaffective). Intervention 2: Second intervention group: Caregivers of patients wi

Sponsors

Alborz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis confirmed by two psychiatrists based on DSM-5-TR "Stable" mental status (operational definition: PANSS score below threshold Age between 18 and 65 years Informed consent

Exclusion criteria

Exclusion criteria: Absence of more than 2 sessions of the intervention Exacerbation of the severity of the disease symptoms requiring immediate hospitalization Intention to withdraw from the study at any stage

Design outcomes

Primary

MeasureTime frame
Depression score on the Beck Depression Inventory. Timepoint: Score measurement of depression at the beginning of the study (before the intervention) and at weeks 6, 8, 10, and 18 after the start of group cognitive-behavioral therapy. Method of measurement: Beck Depression Inventory.;Beck Anxiety Inventory score. Timepoint: Score measurement of anxiety at the beginning of the study (before the intervention) and at weeks 6, 8, 10, and 18 after the start of group cognitive-behavioral therapy. Method of measurement: Beck Anxiety Inventory.;Beck suicide score. Timepoint: Score measurement f suicide at the beginning of the study (before the intervention) and at weeks 6, 8, 10, and 18 after the start of group cognitive-behavioral therapy. Method of measurement: Beck Suicide Questionnaire.;Stigma Score at World Psychiatric Organization Stigma Questionnaire. Timepoint: Score measurement of stigma at the beginning of the study (before the intervention) and at weeks 6, 8, 10, and 18 after the start of group cognitive-behavioral therapy. Method of measurement: World Psychiatric Organization Stigma Questionnaire.;Social Capital Score at Nahapit and Ghoshal Questionnaire. Timepoint: Score measurement of Social Capital at the beginning of the study (before the intervention) and at weeks 6, 8, 10, and 18 after the start of group cognitive-behavioral therapy. Method of measurement: Social Capital Questionnaire Nahapit and Ghoshal Questionnaire.

Secondary

MeasureTime frame
Quality of life score on the quality of life questionnaire. Timepoint: Score measurement of quality of life at the beginning of the study (before the intervention) and at weeks 6, 8, 10, and 18 after the start of group cognitive-behavioral therapy. Method of measurement: Quality of life questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Rahim Badrfam

Alborz University of Medical Sciences

rbadrfam@gmail.com+98 26 3255 1444

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026